Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.31B |
| 2 |
GSK
GSK
|
+$624M |
| 3 |
Meta Platforms (Facebook)
META
|
+$609M |
| 4 |
UnitedHealth
UNH
|
+$335M |
| 5 |
Microsoft
MSFT
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
| 2 |
Toronto Dominion Bank
TD
|
+$216M |
| 3 |
GE Aerospace
GE
|
+$195M |
| 4 |
CF Industries
CF
|
+$193M |
| 5 |
Mondelez International
MDLZ
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.73% |
| 2 | Energy | 8.89% |
| 3 | Industrials | 8.57% |
| 4 | Technology | 7.69% |
| 5 | Communication Services | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Nuveen California Municipal Value Fund
NCA
$303M
| $381K | ﹤0.01% |
37,373
+291
| +0.8% | +$3.05K |
|
3927
Nu Skin
NUS
$234M
| $380K | ﹤0.01% |
5,589
-2,189
| -28% | -$142K |
|
3928
Sturm, Ruger & Co
RGR
$602M
| $380K | ﹤0.01% |
6,822
-10,696
| -61% | -$558K |
|
3929
Theravance Biopharma
TBPH
$881M
| $380K | ﹤0.01% |
13,622
-2,010
| -13% | -$59.5K |
|
|
EQC
3930
DELISTED
Equity Commonwealth
EQC
| $380K | ﹤0.01% |
12,467
-1,355
| -10% | -$41K |
|
|
MGLN
3931
DELISTED
Magellan Health Services, Inc.
MGLN
| $380K | ﹤0.01% |
3,940
-2,058
| -34% | -$182K |
|
3932
Invesco Pennsylvania Value Municipal Income Trust
VPV
$202M
| $379K | ﹤0.01% |
31,199
-6,364
| -17% | -$77.3K |
|
3933
CNX Resources
CNX
$5.28B
| $378K | ﹤0.01% |
25,832
-9,730
| -27% | -$134K |
|
3934
Invesco S&P Spin-Off ETF
CSD
$237M
| $378K | ﹤0.01% |
7,256
+99
| +1% | +$5.09K |
|
3935
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$423M
| $378K | ﹤0.01% |
14,916
+6,497
| +77% | +$160K |
|
3936
Asbury Automotive
ABG
$3.78B
| $377K | ﹤0.01% |
5,907
-1,662
| -22% | -$104K |
|
3937
Black Stone Minerals
BSM
$3.05B
| $375K | ﹤0.01% |
20,899
-19,374
| -48% | -$341K |
|
3938
ProShares UltraShort Russell2000
TWM
$40.4M
| $375K | ﹤0.01% |
1,073
+725
| +208% | +$263K |
|
|
DENN
3939
DELISTED
Denny's
DENN
| $374K | ﹤0.01% |
28,238
-6,083
| -18% | -$79.2K |
|
3940
Vanguard Russell 2000 Value ETF
VTWV
$1.38B
| $374K | ﹤0.01% |
3,405
-315
| -8% | -$34.2K |
|
3941
Freshpet
FRPT
$3.5B
| $373K | ﹤0.01% |
19,668
-2,395
| -11% | -$41.7K |
|
3942
PUT
Southwest Airlines
LUV
$21.7B
| $373K | ﹤0.01% |
5,700
| – | – |
|
3943
V2X
VVX
$2.6B
| $373K | ﹤0.01% |
12,080
-1,014
| -8% | -$32.4K |
|
|
DS
3944
DELISTED
Drive Shack Inc.
DS
| $373K | ﹤0.01% |
67,592
-60,872
| -47% | -$289K |
|
3945
Curis
CRIS
$3.76M
| $372K | ﹤0.01% |
266
-194
| -42% | -$456K |
|
3946
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$540M
| $372K | ﹤0.01% |
3,826
-6,641
| -63% | -$641K |
|
3947
Orion Group Holdings
ORN
$402M
| $372K | ﹤0.01% |
47,542
+13,587
| +40% | +$101K |
|
|
CSTR
3948
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $372K | ﹤0.01% |
17,940
-1,268
| -7% | -$26.3K |
|
3949
Ocular Therapeutix
OCUL
$2.2B
| $371K | ﹤0.01% |
83,383
-80,678
| -49% | -$412K |
|
|
MUS
3950
DELISTED
BLACKROCK MUNIHOLDINGS QUALITY FUND, INC.
MUS
| $370K | ﹤0.01% |
27,690
+5,437
| +24% | +$73.2K |
|
Similar funds
Royal Bank of Canada's Q4 2017 Portfolio in Review
As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.
- Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
- Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
- Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
- Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
- Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.
Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.